QA: BALCHEM CORP in us_medicinal_products/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2019_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 156,000,000
1 LiabilitiesCurrent 126,365,000
2 remainder_Liabilities 7,372,000
3 AssetsCurrent 226,314,000
4 AssetsNoncurrent 6,722,000
5 PropertyPlantAndEquipmentNet 194,339,000
6 Goodwill 553,980,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 524,336,000
9 ResearchAndDevelopmentExpense 11,592,000
10 remainder_Expenses 20,457,000
11 remainder_Revenues 643,679,000
12 remainder_NetIncome -8,721,000
13 remainder_ComprehensiveNetIncome -1,960,000
  yvar yval
0 Liabilities 289,737,000
1 Assets 981,355,000
2 Expenses 556,385,000
3 Revenues 643,679,000
4 StockholdersEquity 691,618,000
5 NetIncome 78,573,000
6 ComprehensiveNetIncome 77,593,000
7 BaseVar 1,240,918,500
8 EconomicCapitalRatio 1.05

Edgar->Model Mapping

Feature Distribution

Change over Time